ArchiMed has acquired four companies: French health ingredients providers HIS (Press release) and Fytexia (Press release); Polyplus (Press release), a maker of transfection reagents; and Micromed (Press release), a French-Italian neurodiagnostic company.
You can listen to Jayne Carrington, Customer and Propositions Director of RehabWorks, interviewed on Share Radio, discussing mental wellbeing in the workplace. Jayne discusses the impact of mental health issues in the workplace and the importance and options for organisations to support the health and wellbeing of their employees. Services such as employee assistance programmes, training for managers and post-trauma support have a positive impact.…
ArchiMed has acquired a majority control of RehabWorks as well as a minority stake in Primo Group s.r.l. Financial terms weren’t announced. U.K.-based RehabWorks is contracted by companies and insurers to manage therapy, rehabilitation, workforce reinsertion and other physical and mental health issues for employees. Primo, of Torino, Italy, operates retail dental clinics in that country.
ArchiMed has acquired a majority controlling stake in Deallus Consulting. No financial terms were disclosed. Based in London, Deallus is a life sciences industry consultant.
ArchiMed has acquired control of Lausanne-based MediStream, a manufacturer and marketer of innovative orthopaedic implants. Archimed was founded earlier this year by Denis Ribon, former global head of healthcare at 3i and three of his former team members.